Analytical Laboratory Reference · ICH Q2(R2) & Sample Traceability
How to Read a Peptide Certificate of Analysis (COA): HPLC Purity vs. Mass Assay & Sample Traceability
Direct Summary: A peptide Certificate of Analysis (COA) reports distinct analytical dimensions that cannot be substituted for one another. ICH Q2(R2) Table 1 distinguishes Impurity (Purity) from Assay (Content/Potency), while §3.1.2.2 addresses specificity/selectivity for assay, purity and impurity procedures. In commercial peptide COAs, RP-HPLC purity (%) is conventionally reported by laboratories as relative UV peak area (typically at 214 nm or 220 nm), whereas mass assay (net peptide content) quantifies the actual amount or concentration of target peptide (mg/vial or mg/mL) using the stated method. Furthermore, by analogy to general laboratory sample-accountability principles, a matching batch or lot number on a PDF does not by itself prove that an untested shipped vial matches the tested specimen or establish sterility or clinical safety.
1. ICH Q2(R2) Analytical Distinction
Chromatographic Purity (%) vs. Mass Assay (Net Content)
The single most common error when evaluating research peptides is mistaking RP-HPLC Purity (%) for Net Peptide Content (Assay). International analytical validation guidance (ICH Q2(R2) Table 1 & §3.1.2.2 [1]) separates impurity/purity procedures from content/potency assays:
- RP-HPLC Purity (% Peak Area — Vendor/Lab Convention): In commercial peptide testing, laboratories conventionally report chromatographic purity as the area of the main target peptide peak relative to total UV-absorbing peptide-related peaks (commonly at 214 nm or 220 nm). Because water, inorganic salts, counter-ions (trifluoroacetate / TFA, acetate), and non-UV excipients (such as mannitol) do not absorb similarly in the chromatogram, a sample can report 99.2% HPLC purity while containing only 7.4 mg of active peptide in a nominally labeled 10 mg vial.
- Mass Assay (Net Peptide Content): Quantifies the amount or concentration of target peptide in the tested sample using the stated calibration standard and method. In general analytical chemistry, gross powder mass, net peptide content, counter-ions/salts, and residual moisture are distinct quantities and are not interchangeable. Note also whether a lab tested a lyophilized vial (
mg/vial) or an already-reconstituted liquid sample reported as concentration (mg/mL; see Janoshik [4]). - Impact on Reconstitution Math: Dilution concentration (
C = Mass / Volume) depends on actual peptide content (mg/vial), while keeping in mind that a batch or sample assay applies to the tested vial(s) and does not guarantee zero vial-to-vial fill variance in an untested vial.
2. Orthogonal Identity Verification
Molecular Weight Confirmation via LC-MS (Daltons)
RP-HPLC retention time alone is not definitive proof of molecular identity because structurally distinct peptides can co-elute under a given gradient. Orthogonal confirmation requires Electrospray Ionization Mass Spectrometry (ESI-MS / LC-MS):
- Multiply Charged Ion Envelope (
m/z): Peptides form protonated ions ([M+2H]2+,[M+3H]3+,[M+4H]4+). Deconvolution must match the theoretical molecular weight of the target sequence:- Retatrutide (CAS 2381089-83-2):
4731.33 Da (g/mol) - Tirzepatide (CAS 2023788-19-2):
4813.45 Da (g/mol) - Semaglutide (CAS 910463-68-2):
4113.58 Da (g/mol) - BPC-157 (CAS 137525-51-0):
1419.53 Da (g/mol)
- Retatrutide (CAS 2381089-83-2):
- Multi-Compound Blends (GLOW 70mg / KLOW 80mg / CagriSema): A valid blend COA must resolve and quantify each individual constituent peak (e.g., GHK-Cu + BPC-157 + TB-500), never just a single combined total.
3. Sample Traceability & Authentication Limits
Why a Matching Lot Number Alone Does Not Prove Sample Traceability
By analogy to general laboratory sample-accountability and chain-of-custody frameworks (such as the archived FDA ORA Field Science and Laboratories Manual [2]), an analytical test result applies strictly to the specific physical specimen received and logged by the testing facility. When reviewing commercial research-supplier COAs, apply three verification checks:
Verify the report’s unique Task ID, Verification Key, or QR link directly on the issuing laboratory’s official domain (e.g., janoshik.com or mzbiolabs.com). A static PDF hosted only on a vendor’s server is classified as Supplier-hosted PDF linked — not independently authenticated with issuing lab.
Never conflate when a price was checked with when a batch was tested. Always separate: (1) Report Test Date (when the lab analyzed the sample), (2) Report Reviewed Date (when the document was inspected), and (3) Price Checked Date.
Standard RP-HPLC and LC-MS reports measure chemical identity, chromatographic purity, and peptide content in the tested sample. Unless separate compendial USP <71> sterility and USP <85> bacterial endotoxin (LAL) procedures are performed, a chemical COA does not establish sterility or endotoxin status — and even when performed on a sample, a sampled result applies to the tested units and does not establish every unit in a batch (USP <71>, <85>, <797> [3]).
4. Worked Documented COA Audits
Side-by-Side Analytical Walkthrough of Documented Retatrutide 10mg Batch PDFs
Below is a line-by-line analytical inspection of two public supplier-hosted COA PDFs currently indexed in our Simms Research vs. True Peptides (19-Peptide COA & Catalog Comparison) and Research Supplier Comparison tables, illustrating how reported test scope and internal arithmetic should be audited.
Simms Research — GLP-3 RT (Retatrutide) 10 mg
- Reported Lot & Dates: Lot
#2026-G460· Test date2026-07-16· Reviewed2026-11-03 - Reported RP-HPLC Purity:
99.611%batch-average chromatographic purity across 3 tested vials. - Reported Mass Assay (Net Content) & Arithmetic Audit: Three individual vials are reported at
10.39 mg,10.74 mg, and11.19 mg. Their arithmetic mean is10.77 mg(matching the lower table value), whereas the top summary banner states10.68 mgnet content. Audit practice: record the 3-vial range (10.39–11.19 mg) and refer the10.68 mgvs.10.77 mgsummary discrepancy to the issuer for clarification. - Authentication Status: Supplier-hosted PDF linked — not independently authenticated with issuing lab.
- Catalog Price Basis (checked 2026-11-02): $84.00 USD standard list ($8.40 per labeled mg; $75.60 USD / $7.56 per labeled mg on eligible new-customer 1st orders with 10% partner code
PEPLAB10).
True Peptides — TP-RT3 (Retatrutide) 10 mg
- Reported Lot & Dates: Lot
#261006· Test date2026-10-14· Reviewed2026-11-03 - Reported Identity & Purity: Reports LC-MS molecular mass identity confirmation and
99.9%RP-HPLC chromatographic purity. - Mass Assay (Net Content) Scope Limit: This PDF does not report a quantitative net peptide content / mass assay (
mg/vial). While it documents LC-MS identity and chromatographic peak purity (99.9%), it cannot establish actualmg/vialfill mass without a separate content assay. - Authentication Status: Supplier-hosted PDF linked — not independently authenticated with issuing lab.
- Catalog Price Basis (checked 2026-11-02): $89.00 USD list ($8.90 per labeled mg; partner referral link
?ref=peplab, no separate buyer discount code confirmed).
5. Printable 1-Page Laboratory Bench Worksheet
Peptide Vial COA & Reconstitution Verification Worksheet
| Verification Field | What to Record Before Reconstitution | Verification & Specification Check | Bench Record (Fill In) |
|---|---|---|---|
| 1. Compound & CAS Registry | Confirm peptide sequence name and CAS number match experimental protocol | Exact CAS & sequence match to protocol | Compound: ________ |
| 2. Vial Lot / Batch Match | Compare physical crimp/label lot number against COA report lot number and test date | Identical lot ID; test date & documented stability/retest window verified | Lot #: __________ |
| 3. Issuing Lab Authentication | Check Task ID / QR code directly on issuing laboratory domain (Janoshik / MZ Biolabs / Kovera) | Verified on lab portal or noted as unauthenticated PDF | Task/Key: ________ |
| 4. RP-HPLC Purity (%) | Record chromatographic peak area percentage and wavelength (e.g., 214 nm / 220 nm) | Meets predefined project/protocol purity specification | Purity: ________ % |
| 5. Mass Assay (Net Content) | Record reported sample/batch assay result (mg/vial or mg/mL) or mark “Not Reported” |
Record sample/batch assay result (note sampling & chain-of-custody limits for untested vials) | Assay: ________ mg |
| 6. Reconstitution Volume | Bacteriostatic water added (mL) → Concentration (mg/mL) → U-100 Units |
Verify in PepLab Calculator | ___ mL → ___ mg/mL |
6. Primary Regulatory & Analytical Sources
References & Methodological Footnotes
- [1] ICH Q2(R2): International Council for Harmonisation of Technical Requirements for Pharmaceuticals for Human Use, Validation of Analytical Procedures — Q2(R2) (Adopted November 2023; Error Correction 2025). Table 1 distinguishes Impurity (Purity) from Assay (Content/Potency); Section 3.1.2.2 addresses specificity/selectivity for assay, purity and impurity procedures. Official ICH PDF (2025 Corrected) ↗
- [2] FDA ORA Laboratory Manual (Archived Analogy Reference): U.S. Food and Drug Administration, Field Science and Laboratories Manual (marked archived by FDA). Cited here by analogy for general laboratory specimen accountability and chain-of-custody principles (that analytical results apply to the custody-verified specimen analyzed), not as a commercial research-supplier rule. FDA Archived Manual Page ↗
- [3] USP <71>, <85>, <621> & <797>: United States Pharmacopeia, General Chapter <71> Sterility Tests (USP <71> Official Preview ↗), General Chapter <85> Bacterial Endotoxins Test (USP <85> Harmonization PDF ↗), General Chapter <621> Chromatography, and General Chapter <797> Pharmaceutical Compounding — Sterile Preparations (USP <797> Reference ↗).
- [4] Janoshik Analytical Documentation: Can I send an already reconstituted peptide sample? Explains that reconstituted liquid peptide samples can be analyzed and reported by concentration (e.g.,
mg/mL). Janoshik Help Article #167 ↗
Analytical & Procurement Reference Series